Metalloproteinase inhibitors and the prevention of connective tissue breakdown

Pharmacology and Therapeutics

Volumn 70, Issue 3, 1996, Pages 163-182

  Cawston, T E ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

collagenase; hydroxamate; metalloproteinase; peptide inhibitor; TIMP; zinc

Indexed keywords

CAPTOPRIL; COLLAGENASE; DOXYCYCLINE; ENALAPRIL; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; MINOCYCLINE; TETRACYCLINE;

ANIMAL TISSUE; BONE; CARTILAGE; CONNECTIVE TISSUE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; JOINT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 0029766216     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(96)00015-0     Document Type: Review

References (245)

1. Aimes, R. T. and Quigley, J. P. (1995) Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J. Biol. Chem. 270: 5872-5876.
2. Andrews, H. J., Edwards, T. A., Cawston, T. E. and Hazleman, B. L. (1989) Transforming growth factor-beta causes partial inhibition of interleukin-1-stimulated cartilage degradation in vitro. Biochem. Biophys. Res. Commun. 162: 144-149.
3. Andrews, H. J., Bunning, R. A. D., Plumpton, T. A., Clark, I. M., Russell, R. G. G. and Cawston, T. E. (1990a) Inhibition of interleukin-1-induced collagenase production in human articular chondrocytes in vitro by recombinant human inteferon-gamma. Arthritis Rheum. 33: 1733-1738.
4. Andrews, H. J., Cawston, T. E. and Halzeman, B. L. (1990b) Modulation of plasminogen activator production by interleukin 1: differential responses of fibroblasts derived from human skin and rheumatoid and non-rheumatoid synovium. Biochim. Biophys. Acta 1051: 94-93.
5. Andrews, H. J., Plumpton, T. A., Harper, G. P. and Cawston, T. E. (1992) A synthetic peptide metalloproteinase inhibitor but not TIMP prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions 37: 147-154.
6. Baragi, V. M., Fliszar, C. J., Conroy, M. C., Ye, Q-Z., Shipley, J. M. and Welgus, H. G. (1994) Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin. J. Biol. Chem. 269: 12692-12697.
7. Barrett, A. J. (1977) Introduction to the history and classification of proteinases. In: Proteinases in Mammalian Cells and Tissues, pp. 1-56, Barrett, A. J. (ed.) Elsevier, Amsterdam.
8. 2M with other proteases. Biochem. J. 133: 709-724.
9. Basset, P., Wolf, C. and Chambon, P. (1993) Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res. Treat. 24: 185-193.
10. Beranger, J-Y., Godeau, G., Frances, C., Robert, L. and Hornebeck, W. (1994) Presence of gelatinase A and metalloelastase type protease at the plasma membrane of human skin fibroblasts. Influence of cytokines and growth factors on cell-associated metalloendopeptidase levels. Cell Biol. Int. 18: 715-722.
11. Bigg, H. F. and Cawston, T. E. (1995) All-trans-retinoic acid interacts synergistically with basic fibroblast growth factor and epidermal growth factor to stimulate the production of tissue inhibitor of metalloproteinases from fibroblasts. Arch. Biochem. Biophys. 319: 74-83.
12. Bigg, H. F., Clark, I. M. and Cawston, T. E. (1994) Fragments of human fibroblast collagenase: interaction with metalloproteinase inhibitors and substrates. Biochim. Biophys. Acta 1208: 157-165.
13. Birkedal-Hansen, H. (1995) Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7: 728-735.
14. Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal Hansen, B., De Carlo, A. and Engler, J. A. (1993) Matrix metalloproteinases: a review. Crit. Rev. Oral. Biol. Med. 4: 197-250.
15. Blundell, T. L. (1994) Metalloproteinase super-families and drug design. Nature Struct. Biol. 1: 73-75.
16. Bodden, M. K., Harber, G. J., Birkedal-Hansen, B., Windsor, L. J., Caterina, N. C. M., Engler, J. A. and Birkedal-Hansen, H. (1994) Functional domains of human TIMP-1 (tissue inhibitor of metalloproteinases) J. Biol. Chem. 269: 18943-18952.
17. Bode, W., Reinemer, P., Huber, R., Kleine, T., Schnierer, S. and Tschesche, H. (1994) The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J. 13: 1263-1269.
18. Borkakoti, N., Winkler, F. K., Williams, D. H., D'Arcy, A., Broadhurst, M. J., Brown, P. A., Johnson, W. H. and Murray, E. J. (1994) Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor. Nature Struct. Biol. 2: 106-110.
19. Breckton, J. J. W., Hembry, R. M., Reynolds, J. J. and Meikle, M. C. (1995) Matrix metalloproteinases and TIMP-1 localization at sites of osteogenesis in the craniofacial region of the rabbit embryo. Anat. Rec. 242: 177-187.
20. Bredveld, F., Dijkmans, B. A. C. and Mattie, H. (1990) Minocycline treatment for rheumatoid arthritis: an open dose finding study. J. Rheumatol. 17: 43-46.
21. Brinckerhoff, C. E. (1990) Retinoids and rheumatoid arthritis: modulation of extracellular matrix by controlling expression of collagenase. Methods Enzymol. 190: 175-188.
22. Brinckerhoff, C. E. (1991) Joint destruction in arthritis: metalloproteinases in the spotlight. Arthritis Rheum. 34: 1073-1075.
23. Brinckerhoff, C. E. and Auble, D. T. (1990) Regulation of collagenase gene expression in synovial fibroblasts. Ann. NY Acad. Sci. 580: 355-374.
24. Brown, P. D. (1994) Clinical trials of a low molecular weight matrix metalloproteinase inhibitor in cancer. Ann. NY Acad. Sci. 732: 217-221.
25. Brown, P. D., Kleiner, D. E., Unswort, E. J. and Stetler-Stevenson, W. G. (1993) Cellular activation of the 72 kDa type IV procollagenase/TMP-2 complex. Kidney Int. 43: 163-170.
26. Browner, M. F., Smith, W. W. and Castelhano, A, L. (1995) Matrilysin-Inhibitor complexes: common themes among metal-loproteases. Biochemistry 34: 6602-6610.
27. Busiek, D. F., Ross, F. P., McDonnell, S., Murphy, G., Matrisian, L. M. and Welgus, H. G. (1992) The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J. Biol. Chem. 267: 9087-9092.
28. Busiek, D. F., Baragi, V., Hehring, L. C., Parks, W. C. and Welgus, H. G. (1995) Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J. Immunol. 154: 6484-6491.
29. Butler, T. A., Zhu, C., Mueller, R. A., Fuller, G. C., Lemaire, W. J. and Woessner, J. F., Jr. (1991) Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463. Biol. Reprod. 44: 1183-1188.
30. Buttle, D. J., Handley, C. J., Ilic, M. Z., Saklatvala, J., Murata, M. and Barrett, A. J. (1993) Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases; evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Arthritis Rheum. 36: 1709-1717.
31. Buttle, D. J., Bramwell, H. and Hollander, A. P. (1995) Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy? Clin. Pathol.: Mol. Pathol. 48: M167-M177.
32. Campbell, I. K., Piccoli, D. S., Roberts, M. J., Muirden, K. D. and Hamilton, J. A. (1990) Effects of tumour necrosis factor on resorption of human articular cartilage and production of plasminogen activators by human articular chondrocytes. Arthritis Rheum. 33: 542-552.
33. Canalis, E., Rydziel, S., Delany, A. M., Varghese, S. and Jeffrey, J. J. (1995) Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures. Endocrinology 136: 1348-1354.
34. Caputo, C. B., Sygowski, L. A., Wolanin, D. J., Patton, S. P., Cacces, A. S., Roberts, R. A. and DiPasquale, G. (1987) Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro. J. Pharmacol. Exp. Ther. 240: 460-465.
35. Case, J. P., Lafyatis, R., Remmers, E. F., Kunkumain, G. K. and Wilder, R. L. (1989a) Stromelysin expression in rheumatoid synovium. Am. J. Pathol. 135: 1055-1064.
36. Case, J. P., Sano, H., Lafyatis, R., Remmers, E. F., Kukkumian, G. K. and Wilder, R. L. (1989b) Stromelysin expression in the synovium of rats with experimental erosive arthritis. J. Clin. Invest. 84: 1731-1740.
37. Cawston, T. E. (1994) Metalloproteinases and connective tissue breakdown. Rheumatol. Rev. 3: 147-154.
38. Cawston, T. E. (1995) Proteinases and connective tissue breakdown. In: Mechanisms and Models in Rheumatoid Arthritis, pp. 333-362, Henderson, B., Edwards, J. C. W. and Pettipher, E. R. (eds.) Academic Press Ltd., London.
39. 2-macroglobulin in the presence of the tissue inhibitor of metalloproteinases. FEBS Lett. 209: 9-11.
40. Cawston, T. E., Galloway, W. A., Mercer, E., Murphy, G. and Reynolds, J. J. (1981) Purification of rabbit bone inhibitor of collagenase. Biochem. J. 195: 159-165.
41. Cawston, T. E., Murphy, G. M., Mercer, E., Galloway, W. A., Hazleman, B. L. and Reynolds, J. J. (1983) The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem. J. 211: 313-318.
42. Cawston, T. E., Weaver, L., Coughlan, R. J., Kyle, M. V. and Hazleman, B. L. (1989) Synovial fluids from infected joints contain active metalloproteinases and no inhibitory activity. Br. J. Rheumatol. 28: 386-392.
43. Clark, I. M. and Cawston, T. E. (1989) Fragments of human fibroblast collagenase. Purification and characterization. Biochem. J. 263: 201-206.
44. Clark, I. M., Powell, L. K., Hazleman, B. L. and Cawston, T. E. (1993) The measurement of collagenase, TIMP and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 36: 372-379.
45. Cockett, M. I., Birch, M. L., Murphy, G., Hart, I. R. and Docherty, A. J. P. (1994) Metalloproteinase domain structure, cellular invasion and metastasis. Biochem. Soc. Trans. 22: 55-57.
46. Collier, S. and Ghosh, P. (1988) The role of plasminogen in IL-1 mediated cartilage degradation. J. Rheumatol. 15: 1129-1137.
47. Cornelius, L. A., Nehring, L. C., Roby, J. D., Parks, W. C. and Welgus, H. G. (1995) Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J. Invest. Dermatol. 105: 170-176.
48. Crabbe, T., O'Connell, J. P., Smith, B. J. and Docherty, A. J. P. (1994a) Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase. Biochemistry 33: 14419-14425.
49. Crabbe, T., Tucker, S., Cockett, M. I., Willenbrock, F., Tickle, S., O'Connell, J. P., Scothern, J. M., Murphy, G. and Docherty, A. J. P. (1994b) Mutation of the active site glutamic acid of human gelatinase. A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1. Biochemistry 33: 6684-6690.
50. Crawford, H. C. and Matrisian, L. M. (1994) Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion & Metastasis 14: 234-245.
51. Crowe, P. D., Walter, B. N., Mohler, K. M., Otten-Evans, C., Black, R. A. and Ware, C. F. (1995) A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 81: 1205-1210.
52. Darlak, K., Miller, R. B., Stack, M. S., Spatola, A, F. and Gray, R. D. (1990) Thiol-based inhibitors of mammalian collagenase. Substituted amide and peptide derivatives of the leucine analogue, 2-[(R,S)-mercaptomethyl]-4-methylpentanoic acid. J. Biol. Chem. 265: 5199-5205.
53. Dayer, J. M., Buettler, B. and Cerami, A. (1985) Cachectin/tumour necrosis factor stimulates collagenase and prostaglandin E2 production by synovíal cells and dermal fibroblasts. J. Exp. Med. 162: 2163-2168.
54. Dean, D. D., Martel-Pelletier, J., Pelletier, J. P., Howell, D. S. and Woessner, J. F. (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84: 678-685.
55. DeClerck, Y. A. and Imren, S. (1994) Protease inhibitors: role and potential therapeutic use in human cancer. Eur. J. Cancer (A) 30A: 2170-2180.
56. DeClerck, Y. A., Yean, T. D., Ratskin, B. J., Lu, H. S. and Langly, K. E. (1989) Purification and characterisation of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J. Biol. Chem. 264: 17445-17455.
57. Delany, A. M. and Brinckerhoff, C. E. (1992) Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J. Cell. Biochem. 50: 400-410.
58. Denhardt, D. T., Feng, B., Edwards, D. R., Cocuzzi, E. T. and Malyankar, U. M. (1993) Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol. Ther. 59: 329-341.
59. Devarajan, P., Johnston, J. J., Ginsberg, S. S., Van Wart, H. E. and Berliner, N. (1992) Structure and expression of neutrophil gelatinase cDNA. Identity with type IV collagenase from HT1080 cells. J. Biol. Chem. 267: 25228-25232.
60. DiMartino, M. J., Wolff, C. E., High, W., Crimmin, M. J. and Galloway, W. A. G. (1991) Antiinflammatory and chondroprotective activities of a potent metalloproteinase inhibitor. J. Cell. Biochem. 45 (Suppl. E): 179.
61. Dingle, J. T., Horner, A. and Shield, M. (1991) The sensitivity of synthesis of human cartilage matrix to inhibition by IL-1 suggests a mechanism for the development of osteoarthritis. Cell Biochem. Funct. 9: 99-102.
62. DiPasquale, G., Caccese, R., Pasternak, R., Conaty, J., Hubbs, S. and Perry K. (1986) Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents. Proc. Soc. Exp. Biol. Med. 183: 262-267.
63. Docherty, A. J. P., O'Connell, J., Crabbe, T., Angal, S. and Murphy, G. (1992) The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol. 10: 200-207.
64. Ellis, A. J., Curry, V. A., Powell, L. K. and Cawston T. E. (1994) The prevention of collagen brekadown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor. Biochem. Biophys. Res. Comm. 201: 94-101.
65. Emmert-Buck, M. R., Roth, M. J., Zhuang, Z., Campo, E., Rozhin, J., Sloane, B. F., Liotta, L. A. and Stetler-Stevenson, W. G. (1995) Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumour regions of human colon cancer samples. Am. J. Pathol. 145: 1285-1290.
66. Engelmyer, E., Van Goor, H., Edwards, D. R. and Diamond, J. R. (1995) Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis. J. Am. Soc. Nephrol. 5: 1675-1683.
67. Everts, V., Delaiss, J-M, Korper, W., Niehof, A., Ves, G. and Beertsen, W. (1992) Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteineproteinases and matrix metalloproteinases. J. Cell Physiol. 150: 221-231.
68. Fields, G. B., Van Wart, H. E. and Birkendale-Hansen, H. (1987) Sequence specificity of human synovial fibroblast collagenase. J. Biol. Chem. 262: 6221-6226.
69. Fields, G. B., Netzel-Arnett, S. J. N., Windsor, L. J., Engler, J. A., Birkedal-Hansen, H. and Van Wart, H. E. (1990) Proteolytic activities of human fibroblast collagenase: hydrolysis of a broad range of substrates at a single active site. Biochemistry 29: 6670-6677.
70. Freestone, T., Turner, R. J., Coady, A., Higman, D. J., Greenhalgh, R. M. and Powell, J. T. (1995) Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 15: 1145-1151.
71. Freije, J. M. P., Diez-Itza, I., Balbin, M., Sanchez, L. M., Blasco, R., Tolivia, J. and Lopez-Otin, C. (1994) Molecular cloning and expression of collagenase-3, a novel human matrixmetalloproteinase produced by breast carcinomas. J. Biol. Chem. 269: 16766-16773.
72. Gadher, S. J., Eyre, D. R., Wotton, S. F., Schmid, T. M. and Woolley, D. E. (1990) Degradation of cartilage collagens type II, IX, X and XI by enzymes derived from human articular chondrocytes. Matrix 10: 154-163.
73. Gaire, M., Magbanua, Z., McDonnell, S., McNeil, L., Lovett, D. H. and Matrisian, L. M. (1992) Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J. Biol. Chem. 269: 2032-2040.
74. Galardy, R. E., Grobelny, D., Foellmer, H. G. and Fernandez, L. A. (1994) Inhibition of N-[2R-2-(hydroxamidocarbonyemethyl)-4-methylpentanoydl)]-L-tryp tophan methylamide. Cancer Res. 54: 4715-4718.
75. Gavrilovic, J. and Murphy, G. (1989) The role of plasminogen in cell-mediated collagen degradation. Cell Biol. Int. Rep. 13: 367-375.
76. Gearing, A. J., Beckett, P., Christodoulou, M. and Churchill, M. (1994) Processing of tumour necrosis factor-a precursor by metalloproteinases. Nature 370: 555-557.
77. Ghose, A. K., Logan, M. E., Treasurywala, A. M., Wang, H., Wahl, R. C., Tomczuk, B. E., Gowravaram, M. R., Jaeger, E. P. and Wendoloski, J. J. (1995) Determination of pharmacophoric geometry for collagenase inhibitors using a novel computational method and its verification using molecular dynamics, NMR, and X-ray crystallography. J. Am. Chem. Soc. 117: 4671-4682.
78. Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T. and Marmer, B. L. (1992) Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267: 4583-4591.
79. Goldring, M. B. (1993) Degradation of articular cartilage in culture: regulatory factors. In: Joint Cartilage Degradation, pp. 281-346, Woessner, J. F. and Howell, D. S. (eds.) Marcel Dekker, New York.
80. Gooley, P. R., Johnson, B. A., Marcy, A. I., Cuca, G. C., Salowe, S. P., Hagmann, W. K., Esser, C. K. and Springer, J. P. (1993) Secondary structure and zinc ligation of human recombinant short-form stromelysin by multidimensional heteronuclear NMR. Biochemistry 32: 13098-13108.
81. Gordon, J. L., Drummond, A. H. and Galloway, W. A. (1993) Metalloproteinases as therapeutics. Clin. Exp. Rhematol. 11 (Suppl. 8): S91-S94.
82. Grams, F., Reinemer, P., Powers, J. C., Kleine, T., Pieper, M., Tschesche, H., Huber, R. and Bode, W. (1995) X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Eur. J. Biochem. 228: 830-841.
83. Granstrm, L. M., Ekman, G. E., Malmstrm, A., Ulmsten, U. and Woessner, J. F., Jr. (1992) Serum collagenase levels in relation to the state of the human cervix during pregnancy and labor. Am. J. Obstet. Gynecol. 167: 1284-1288.
84. Gray, R. D. and Paterson, C. A. (1994) Application of peptide-based matrix metalloproteinase inhibitors in corneal ulceration. Ann. NY Acad. Sci. 732: 206-216.
85. Gray, S. D., Saneii, H. H. and Spatola, A. F. (1981) Metal peptide inhibitors of vertebrate collagenase. Biochem. Biophys. Res. Commun. 101: 1251-1258.
86. Greenwald, R. A. (1994) Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines. Ann. NY Acad. Sci. 732: 181-198.
87. Greenwald, R., Golub, L. M., Laveites, B., Ramamurthy, N. S., Laskin, R. and Gruber, B. (1987) Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J. Rheumatol. 14: 28-32.
88. Greenwald, R., Moak, S. A., Ramumurthy, N. S. and Golub, L. M. (1992) Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J. Rheumatol. 19: 927-938.
89. Gren, M. S., Taplin, C. J., Woessner, J. R., Jr., Eaglstein, W. H. and Mertz, P. M. (1992) Collagenase in wound healing: effect of wound age and type. J. Invest. Dermatol. 99: 709-714.
90. Gross, J. and Lapierre, C. M. (1962) Collagenenolytic activity in amphibian tissues; a tissue culture assay. Proc. Natl. Acad. Sci. 54: 1197-1204.
91. Gruber, B. L., Marchese, M. J., Suzuki, K., Schwartz, L. B., Okada, Y., Nagase, H. and Ramamurthy, N. S. (1989) Synovial procollagenase activation by human mast cell tryptase-dependance on matrix metalloproteinase-3 activation. J. Clin. Invest. 84: 1657-1662.
92. Hanglow, A. C., Lugo, A., Walsky, R., Finch-Arietta, M., Lusch, L., Visnick, M. and Fotouhi, N. (1993) Peptides based on the conserved prodomain sequence of matrix metalloproteinases inhibit human stromelysin and collagenase. Agents Actions 39 (Special Conference Issue): C148-C150.
93. Hardingham, T. E. and Fosang, A. J. (1992) Proteoglycans: many forms and many functions. FASEB J. 6: 861-870.
94. Haruyama, H., Ohkuma, Y., Nagaki, H., Ogita, T., Tamaki, K. and Kinoshita, T. (1994) Matlystatins, new inhibitors of type IV collagenases from Actinomadura atramentaria. III. Structure elucidation of matlystatins A to F. J. Antibiot. 47: 1473-1480.
95. Hasty, K. A., Pourmotabbed, T. F., Goldberg, G. I., Thompson, J. P., Spinella, D. G., Stevens, R. M. and Mainardi, C. L. (1990) Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J. Biol. Chem. 265: 11421-11424.
96. He, C., Wilhelm, S. M., Pentland, A. P., Marmer, B. L., Grant, G. A., Eisen, A. Z. and Goldberg, G. I. (1989) Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. USA 86: 2632-2636.
97. Hembry, R. M., Bagga, M. R., Murphy, G., Henderson, B. and Reynolds, J. J. (1993) Rabbit models of arthritis; immunolocalization of collagenase and TIMP in synovium and cartilage. Am. J. Pathol. 143: 628-642.
98. Hembry, R. M., Bagga, M. R., Reynolds, J. J. and Hamblen, D. L. (1995) Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann. Rheum. Dis. 54: 25-32.
99. Henderson, B. and Davies, D. E. (1991) The design of inhibitors of cartilage breakdown. Osteoarthritis: research and prospects for pharmacological intervention. In: Pharmacology and Therapy -Past and Future, pp. 203-215, Russell, R. G. G. (ed.) VCH, Inc.
100. Henderson, B., Doherty, A. J. P. and Beeley, N. R. A. (1990) Design of inhibitors of articular cartilage destruction. Drugs Future 15: 490-508.
101. Hill, P. A., Murphy, G., Docherty, A. J. P., Hembry, R. M., Millican, T. A., Reynolds, J. J. and Meikle, M. C. (1994) The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J. Cell Sci. 107: 3055-3064.
102. Himelstein, B. P., Canete-Soler, R., Bernhard, E. J., Dilks, D. W. and Muschel, R. J. (1994) Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion & Metastasis 14: 246-258.
103. Hirose, T., Patterson, C., Pourmotabbed, T., Mainardi, C. L. and Hasty, K. A. (1993) Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity. Proc. Natl. Acad. Sci. USA 90: 2569-2573.
104. Hodges, D. J., Lee, D. C., Salter, C. J., Reid, D. G., Harper, G. P. and Cawston, T. E. (1994) Purification and secondary structural analysis of tissue inhibitor of metalloproteinases-1. Biochim. Biophys. Acta 1208: 94-100.
105. Hodgson, J. (1995) Remodelling MMPIs. Matrix metalloproteinase inhibitors will be approved as drugs, probably this year, but questions remain concerning their specificity, bioavailability, and potential long-term toxicity. Biotechnology 13: 554-557.
106. Hollander, A. P., Heathfield, T. F., Webber, C., Iwata, Y., Bourne, R., Rorabeck, C. and Poole, A. R. (1994) Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J. Clin. Invest. 93: 1722-1732.
107. Imai, K., Yokohama, Y., Nakanishi, I., Ohuchi, E., Fujii, Y., Nakai, N. and Okada, Y. (1995) Matrix metalloproteinase-7 (Matrilysin) from human rectal carcinoma cells. J. Biol. Chem. 270: 6691-6697.
108. Ito, A., Nakajima, S., Sasaguri, Y., Nagase, H. and Mori, Y. (1995) Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br. J. Cancer 71: 1039-1045.
109. Johnson, W. H., Roberts, N. A. and Borkakoti, N. (1987) Collagenase inhibitors: their design and potential therapeutic use. J. Enzyme Inhib. 2: 1-22.
110. Jubb, R. W. and Fell, H. B. (1980) The breakdown of collagen by chondrocytes. J. Pathol. 130: 159-162.
111. Karran, E. H. and Harper, G. P. (1995) Collagen degradation within subcutaneous air pouches in vivo: the effects of proteinase inhibitors. J. Pharmacol. Toxicol. Methods 34: 97-102.
112. Karran, E. H., Dodgson, K., Harris, S. J., Markwell, R. E. and Harper, G. P. (1995) A simple in vivo model of collagen degradation using collagen-gelled cotton buds: the effects of collagenase inhibitors and other agents. Agents Actions 44: 36-46.
113. Kishnani, N. S., Staskus, P. W., Yang, T-T., Masiarz, F. R. and Hawkes, S. P. (1994) Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix. Matrix Biol. 14: 479-488.
114. Kleiner, D. E., Jr. and Stetler-Stevenson, G. (1993) Structural biochemistry and activation of matrix metalloproteases. Curr. Biol. 5: 891-897.
115. Knauper, V., Kramer, S., Reinke, H. and Tschesche, H. (1990) Characterization and activation of procollagenase from human polymorphonuclear leukocytes. Eur. J. Biochem. 189: 295-300.
116. Knauper, V., Wilhelm, S. M., Seperack, P. K., DeClerck, Y. A., Langley, K. E., Osthues, A. and Tschesche, H. (1993) Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem. J. 295: 581-586.
117. Kortylewicz, Z. P. and Galardy, R. E. (1988) Phosphoramidate peptide inhibitors of human skin fibroblast collagenase. J. Med. Chem. 33: 263-273.
118. Kuettner, K. E. (1992) Biochemistry of articular cartilage in health and disease. Clin. Biochem. 25: 155-163.
119. Lacraz, S., Nicod, L., Galve-de Rochemonteix, B., Baumberger, C., Dayer J-M. and Welgus, H. G. (1992) Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90: 382-388.
120. Lacraz, S., Isler, P., Vey, E., Welgus, H. G. and Dayer, J-M. (1994) Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J. Biol. Chem. 269: 22027-22033.
121. 374) is a primary event in proteolysis of the interglobular domain. J. Biol. Chem. 270: 2550-2556.
122. Lauhio, A., Konttinen, Y. T., Tschesche, H., Nordstrm, D., Salo, T., Lhdevirta, J., Golub, L. M. and Sorsa, T. (1994) Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritis. Antimicrob. Agents Chemother. 38: 400-402.
123. Leco, K. J., Hayden, L. J., Sharma, R. R., Rocheleau, H., Greenberg, A. H. and Edwards, D. R. (1992) Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Haras-transformed murine fibroblasts. Gene 117: 209-217.
124. Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P. and Edwards, D. R. (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269: 9352-9360.
125. Lee, W., Aitken, S., Sodek, J. and McCulloch, C. A. G. (1995) Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J. Periodontal Res. 30: 23-33.
126. Lees, M., Taylor, M. J. and Woolley, D. E. (1994) Mast cell proteinases activate precurser forms of collagenase and stromelysin, but not of gelatinase A and B. Eur. J. Biochem. 223: 171-177.
127. Legendre, P., Richards, C. D., Rafferty, J. A., Dew, G. W. and Reynolds, J. J. (1993) The expression of matrix metalloproteinases and their inhibitors by pig synovial cells and their regulation by combinations of cytokines and growth factors. Comp. Biochem. Physiol. 106B: 691-704.
128. Lelievre, Y., Bouboutou, R., Boiziau, J., Faucher, D., Achard, D. and Cartwright, T. (1990) Low molecular weight, sequence based, collagenase inhibitors selectively block the interaction between collagenase and TIMP (tissue inhibitor of metalloproteinases). Matrix 10: 292-299.
129. Li, J., Brick, P., O'Hare, M. C., Skarzynski, T., Lloyd, L. F., Curry, V. A., Clark, I. M., Bigg, H. F., Hazleman, B. L., Cawston, T. E. and Blow, D. M. (1995) Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed β-propeller. Structure 3: 541-549.
130. Liotta, L. A. (1990) The role of cellular proteases and their inhibitors in invasion and metastasis. Introductionary overview. Cancer Metastasis Rev. 9: 285-287.
131. Lotz, M. and Guerne, P-A. (1991) Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythyroid potentiating activity (TIMP-1/EPA). J. Biol. Chem. 266: 2017-2020.
132. Lovejoy, B., Cleasby, A., Hassell, A. M., Longley, K., Luther, M. A., Weigl, D., McGeehan, G., McElroy, A. B., Drewry, D., Lambert, M. H. and Jordan, S. R. (1994) Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 263: 375-377.
133. Luhio, A., Salo, T., Ding, Y., Konttinen, Y. T., Nordstrm, D., Tschesche, H., Lhdevirta, J., Golub, L. M. and Sorsa, T. (1994) In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis. Clin. Exp. Immunol. 98: 21-28.
134. MacNaul, K. L., Chartrain, N., Lark, M., Tocci, J. and Hutchinson, N. I. (1990) Discoordinate expression of stromelysin, collagenase and TIMP in human rheumatoid synovial fibroblasts: synergistic effects of IL-1 and TNF on stromelysin expression. J. Biol. Chem. 265: 17238-17245.
135. Mallya, S. K., Mookhtiar, K. A., Gao, Y., Brew, K., Dioszegi, M., Birkedal-Hansen, H. and Van Wart, H. E. (1990) Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase. Biochemistry 29: 10628-10634.
136. Matsubara, M., Girard, M. T., Kublin, C. L., Cintron, C. and Fini, M. E. (1991) Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev. Biol. 147: 425-439.
137. Matthews, B. W., Jansonius, J. N., Coleman, P. M., Schoenborn, B. P. and Dupourque, E. (1972) Three dimensional structure of thermolysin. Nature New Biol. 238: 37-41.
138. Mattot, V., Raes, M. B., Henriet, P., Eeckhout, Y., Stehelin, D., Vandenbunder, B. and Desbiens, X. (1995) Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis. J. Cell Sci. 108: 529-535.
139. Matrisian, L. M. (1992) The matrix degrading proteinases Bioessays 14: 455-463.
140. McGeehan, G. M., Becherer, J. D., Bast, R. C., Jr., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., McElroy, A. B., Nichols, J., Pryzwansky, K. M., Schoenen, F., Sekut, L., Truesdale, A., Verghese, M., Warner, J. and Ways, J. P. (1994) Regulation of a tumour necrosis factor-α processing by a metalloproteinase inhibitor. Letter. Nature 370: 558-561.
141. Melchiori, A., Albini, J., Ray, M. and Stetler-Stevenson, W. G. (1992) Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. Cancer Res. 52: 2353-2356.
142. Miltenburg, A. M. M., Lacraz, S., Welgus, H. G. and Dayer, J-M. (1995) Immobilised anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J. Immunol. 154: 2655-2667.
143. Mitchell, T. I., Jeffrey, J. J., Palmiter, R. D. and Brinckherhoff, C. E. (1993) The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. Biochim. Biophys. Acta 1156: 245-254.
144. Mookhtiar, K. A., Marlowe, C. K., Bartlett, P. A. and Van Wart, H. E. (1987) Phosphonamidate inhibitors of human neutrophil collagenase. Biochemistry 26: 1962-1965.
145. Mort, J. S., Dodge, G. R., Roughley, P. J., Liu, J., Finch, S. J., DiPasquale, G. and Poole, A. R. (1993) Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix 13: 95-102.
146. Murphy, G. and Hembry, R. M. (1992) Proteinases in rheumatoid arthritis. J. Rheumatol. 19 (Suppl. 32): 61-64.
147. Murphy, G. and Willenbrock, F. (1995) Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 248: 496-510.
148. Murphy, G., Cockett, M. I., Ward, R. V. and Docherty, A. J. P. (1991a) Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277: 277-279.
149. Murphy, G., Houbrechts, A., Cockett, M. I., Williamson, R. A., O'Shea, M. and Docherty, A. J. P. (1991b) The N-terminal domain of TIMP retains metalloproteinase inhibitor activity. Biochemistry 30: 8097-8102.
150. Murphy, G., Allan, J. A., Willenbrock, F., Cockett, M. I., O'Connell, J. P. and Docherty, A. J. P. (1992a) The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 267: 9612-9618.
151. Murphy, G., Atkinson, S., Ward, R., Gavrilovic, J. and Reynolds, J. J. (1992b) The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann. NY Acad. Sci. 667: 1-12.
152. Murphy, G., Willenbrock, F., Ward, R. V., Cockett, M. I., Eaton, D. and Docherty, A. J. P. (1992b) The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem. J. 283: 637-641.
153. Murphy, G., Segain, J-P., O'Shea, M., Cockett, M., Ioannou, C., Lefebvre, O., Chambon, P. and Basset, P. (1993) The 28-kDa N-terminal domain of the mouse stromelysin-3 has the general properties of a weak metalloproteinases. J. Biol. Chem. 268: 15435-15441.
154. Netzel-Arnett, S., Fields, G., Birkedal-Hansen, H. and Van Wart, H. E. (1991) Sequence specificities of human fibroblast and neutrophil collagenases. J. Biol. Chem. 266: 6747-6755.
155. Netzel-Arnett, S., Sang, Q-X., Moore, W. G. I., Navre, M., Birkedal-Hansen, H. and Van Wart, H. E. (1993) Comparative sequence specificities of human 72- and 93-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry 34: 6427-6432.
156. Newby, A. C., Southgate, K. M. and Davies, M. (1994) Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis. Basic Res. Cardiol. 89 (Suppl. 1): 59-70.
157. Newman, K. M., Ogata, Y., Malon, A. M., Irizarry, E., Gandhi, R. H., Nagase, H. and Tilson, M. D. (1993) Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler. Thromb. 14: 1315-1320.
158. Nikkari, S. T., O'Brien, K. D., Ferguson, M., Hatsukami, T., Welgus, H. G., Alpers, C. E. and Clowes, A. W. (1995) Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92: 1393-1398.
159. Nixon, J. S., Bottomley, K. M. K., Broadhurst, M. J., Brown, P. A., Johnson, W. H., Lawton, G., Marley, J., Sedgwick, A. D. and Wilkinson, S. E. (1991) Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro. Int. J. Tissue React. 13: 237-243.
160. Nomura, H., Sato, H., Seiki, M., Mai, M. and Okada, Y. (1995) Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 55: 3263-3266.
161. Ochieng, J., Fridman, R., Nagia-Makker, P., Kleiner, D. E., Liotta, L. A., Stetler-Stevenson, W. G. and Raz, A. (1994) Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry 33: 14109-14114.
162. Odake, S., Morita, Y., Morikawa, T., Yoshida, N., Hari, H. and Nagai, Y. (1994) Inhibition of matrix metalloproteinases by peptidyl hydroxamic acids. Biochem. Biophys. Res. Commun. 199: 1442-1446.
163. Okada, A., Bellocq, J-P., Rouyer, N., Chenard, M-P., Rio, M-C., Chambon, P. and Basset, P. (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA 92: 2730-2734.
164. Okada, Y., Ganoji, Y., Nakanishi, I., Nagase, H. and Hayakawa, T. (1990) Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virchows Arch. B 59: 305-312.
165. Okada, Y., Naka, K., Kawamura, K., Matsumoto, T., Nakanishi, I., Fujimoto, N., Sato, H. and Seiki, M. (1995) Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab. Invest. 72: 311-322.
166. O'Shea, M., Willenbrock, F., Williamson, R. A., Cockett, M. I., Freedman, R. B., Reynolds, J. J., Docherty, A. J. P. and Murphy, G. (1992) Site-directed mutations that alter the inhibitor activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13. Biochemistry 31: 10146-10152.
167. Osteen, K. G., Rodgers, W. H., Gaire, M., Hargrave, J. T., Gorstein, F. and Matrisian, L. M. (1994) Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc. Natl. Acad. Sci. USA 91: 10129-10133.
168. Overall, C. M. (1994) Regulation of tissue inhibitor of matrix metalloproteinase expresson. Ann. NY Acad. Sci. 732: 51-64.
169. Pei, D. and Weiss, S. J. (1995) Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375: 244-247.
170. Pei, D., Majmudar, G. and Weiss, S. J. (1994) Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269: 25849-25855.
171. Peterson, M. J., Woodley, D. T., Stricklin, G. P. and O Keefe, E. J. (1987) Production of procollagenase by cultured human keratinocytes. J. Biol. Chem. 262: 835-840.
172. Phadke, K. (1987) FGF enhances the IL-1 mediated chondrocytic protease release. Biochem. Biophys. Res. Commun. 142: 448-453.
173. Porras-Reyes, B. H., Blair, H. C., Jeffrey, J. J. and Mustoe, T. A. (1991) Collagenase production at the border of granulation tissue in a healing wound: macrophage and mesenchymal collagenase production in vivo. Connect. Tissue Res. 27: 63-71.
174. Prockop, D. J. and Kivirikko, K. I. (1995) Collagens; molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 64: 403-434.
175. Rawdanowicz, T. J., Hampton, A. L., Nagase, H., Woolley, D. E. and Salamonsen, L. A. (1994) Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 and tumour necrosis factor. J. Clin. Endocrinol. Metab. 79: 530-536.
176. Reponen, P., Leivo, I., Sahlberg, C., Apte, S. S. and Olsen, B. R. (1995) 92-kDa type IV collagenase and TIMP-3, but not 73-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation. Dev. Dyn. 202: 388-396.
177. Richards, C. D., Shoyab, M., Brown T. J. and Gauldi, J. (1993) Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J. Immunol. 150: 5596-5603.
178. Ries, C. and Petrides, P. E. (1995) Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe Seyler 376: 345-355.
179. Rodgers, W. H., Osteen, K. G., Matrisian, L. M., Navre, M., Giudice, L. C. and Garstein, F. (1993) Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am. J. Obstet. Gynecol. 168: 253-260.
180. Rodgers, W. H., Matrisian, L. M., Giudice, L. C., Dsupin, B., Canon, P., Svitek, C., Garstein, F. and Osteen, K. G. (1994) Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J. Clin. Invest. 94: 936-953.
181. Rouyer, N., Wolf, C., Chenard, M. P., Rio, M. C., Chambon, P., Bellocq, J. P. and Basset, P. (1995) Stromelysin-3 gene expression in human cancer: an overview. Invasion & Metastasis 14: 269-275.
182. Saarialho-Kere, U. K., Change, E. S., Welgus, H. G. and Parks, W. C. (1992) Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J. Clin. Invest. 90: 1952-1957.
183. Saarialho-Kere, U. K., Pentland, A. P., Birkedal-Hansen, H., Parks, W. C. and Welgus, H. G. (1994) Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J. Clin. Invest. 94: 79-88.
184. Saklatvala, J., Pilsworth, L. M. C., Sarsfield, S. J., Gavinlovic, J. and Heath, J. (1984) Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase and thymocyte proliferation is augmented in response to one protein. Biochem. J. 224: 461-466.
185. Salamonsen, L. A., Nagase, H. and Woolley, D. E. (1995) Matrix metalloproteinases and their tissue inhibitors at the ovine trophoblast-uterine interface. J. Reprod. Fertil. 103 (Suppl. 49): 29-37.
186. Salo, T., Lyons, J. G., Rahemtulla, F., Birkedal-Hansen, H. and Larjava, H. (1991) TGFB upregulates Type IV collagenase in cultured human keratinocytes. J. Biol. Chem. 266: 11436-11441.
187. Sanchez-Lopez, R., Alexander, C. M., Behrendtsen, O., Breathnach, R. and Werb, Z. (1992) Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins. J. Biol. Chem. 10: 7238-7247.
188. Sandy, J. D., Flannery, C. R., Neame, P. J. and Lohmander, L. S. (1992) The structure of aggrecan fragments in human synovial fluid: evidence for the involvement in osteoarthritis of a novel proteinase. J. Clin. Invest. 89: 1512-1516.
189. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
190. Sato, T., Ito, A., Mori, Y., Yamashita, K., Hayakawa, T. and Nagase, H. (1991) Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prosteomelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17a. Biochem. J. 275: 645-650.
191. Schnierer, S., Kleine, T., Gote, T., Hillemann, A., Knuper, V. and Tschesche, H. (1993) The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity. Biochem. Biophys. Res. Commun. 191: 319-326.
192. Schwartz, M. A., Venkataraman, S., Ghaffari, M. A., Libby, A., Mookhtiar, K. A., Mallya, S. K., Birkedal-Hansen, H. and Van Wart, H. E. (1991) Inhibition of human collagenases by sulfur-based substrate analogs. Biochem. Biophys. Res. Commun. 176: 173-179.
193. Seed, M. P., Thomson, T. A. and Gardner, C. R. (1991) Investigation of the role of metalloproteinases in recombinant human interleukin-1β-induced degradation of rat femoral head cartilage. Drugs Exp. Clin. Res. 17: 355-361.
194. Senior, R. M., Griffin, G. L., Fliszar, C. J., Shapiro, S. D., Goldberg, G. I. and Welgus, H. G. (1991) Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266: 7870-7875.
195. Shapiro, S. D., Campbell, E. J., Kobayashi, D. K. and Welgus, H. G. (1990) Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J. Clin. Invest. 86: 1204-1210.
196. Shapiro, S. D., Campbell, E. J., Konayashi, D. K. and Welgus, H. G. (1991) Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J. Immunol. 146: 2724-2729.
197. Shapiro, S. D., Griffin, G. L., Gkilbert, D. J., Jenkins, M. A., Copeland, N. G., Welgus, H. G., Senior, R. M. and Ley, T. J. (1992a) Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J. Biol. Chem. 267: 4664-4671.
198. Shapiro, S. D., Kobayashi, D. K. and Welgus, H. G. (1992b) Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of the metalloproteinases and TIMP-1. J. Biol. Chem. 267: 13890-13894.
199. Shapiro, S. D., Kobayashi, D. K. and Ley, T. J. (1993) Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268: 23824-23829.
200. Shapiro, S. D., Fliszar, C. J., Broekelmann, T. J., Mecham, R. P., Senior, R. M. and Welgus, H. G. (1995) Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. J. Biol. Chem. 270: 6351-6356.
201. Silbiger, S. M., Jacobsen, V. L., Cupples, R. L. and Koski, R. A. (1994) Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene 141: 293-297.
202. Sires, U. I., Griffin, G. L., Broekelmann, T. J., Mecham, R. P., Murphy, G., Chung, A. E., Welgus, H. G. and Senior, R. M. (1993) Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J. Biol. Chem. 268: 2069-2074.
203. 1-antitrypsin. Biochem. Biophys. Res. Commun. 204: 613-620.
204. Sledge, G. W., Qualai, M., Goulet, R., Bone, E. A. and Fife, R. (1995) Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J. Natl. Cancer Inst. 87: 1546-1550.
205. Sorsa, T., Suomalainen, K. and Uitto, V-J. (1990) The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases. Arch. Oral Biol. 35 (Suppl.): 193S-196S.
206. Sottrup-Jensen, L. and Birkedal-Hansen, H. (1989) Human fibroblast collagenase α-2-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian α-2-macroglobulins. J. Biol. Chem. 264: 15781-15789.
207. 73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc. Natl. Acad. Sci. USA 87: 364-368.
208. Spurlino, J. C., Smallwood, A. M., Carlton, D. D., Banks, T. M., Vavra, K. J., Johnson, J. S., Cook, E. R., Falvo, J., Wahl, R. C. and Pulvino, T. A. (1994) 1.56 A structure of mature truncated human fibroblast collagenase. Proteins Struct. Funct. Genet. 19: 98-109.
209. Stack, M. S., Emberts, C. G. and Gray, R. D. (1991) Application of N-carboxyalkyl peptides to the inhibition and affinity purification of the porcine matrix metalloproteinases collagenase, gelatinase, and stromelysin. Arch. Biochem. Biophys. 287: 240-249.
210. Stetler-Stevenson, W. G. (1995) Progelatinase A activation during tumor cell invasion. Invasion & Metastasis 14: 259-268.
211. Stetler-Stevenson, W. G., Krutsch, H. C. and Liotta, L. A. (1989) Tissue inhibitor of metalloproteinase (TIMP-2). J. Biol. Chem. 264: 17374-17378.
212. Stricklin, G. P. and Welgus, H. G. (1983) Human skin fibroblast collagenase inhibitor purification and biochemical characterization. J. Biol. Chem. 258: 12252-12258.
213. Strongin, A. Y., Marmer, B. L., Grant, G. A. and Goldberg, G. I. (1993) Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268: 14033-14039.
214. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A. and Goldberg, G. I. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270: 5331-5338.
215. Suomalainen, K., Sorsa, T., Golub, L. M., Ramamurthy, N., Lee, H. M., Uitto, V-J., Saari, H. and Konttinen, Y. T. (1992) Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob. Agents Chemother. 36: 227-229.
216. Suzuki, K., Ngase, H., Ito, A., Enghild, J. J. and Salvesen, G. (1990) The role of matrix metalloproteinase 3 in the stepwise activation of human rheumatoid synovial procollagenase. Biol. Chem. Hoppe Seyler 371 (Suppl.): 305-310.
217. Suzuki, K., Lees, M., Newlands, G. F. J., Nagase, H. and Woolley, D. E. (1995) Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II. Biochem. J. 305: 301-306.
218. Takino, T., Sato, H., Shinagawa, A. and Seiki, M. (1995a) Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library-MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270: 23013-23020.
219. Takino, T., Sato, H., Yamamoto, E. and Seiki, M. (1995b) Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain. Gene 155: 293-298.
220. Tamaki, K., Kurihara, S., Oikawa, T., Tanzawa, K. and Sugimura, Y. (1994) Matlystatins, new inhibitors of type IV collagenases from Actinomadura atramentaria. IV Synthesis and structure-activity relationships of matlystatin B and its stereoisomers. J. Antibiot. 47: 1481-1492.
221. Tokuraku, M., Sato, H., Murakami, S., Ikada, Y., Watanabe, Y. and Seiki, M. (1995) Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int. J. Cancer 64: 355-359.
222. Tryggvason, K. (1995) Molecular biology and pathophysiology of collagens. Molecular properties and diseases of collagens. Kidney Int. 47 (Suppl. 49): S-24-S-28.
223. Tyler, J. A., Bird, J. L. E. and Giller, T. (1990) Interleukin-1 inhibits the production of types II, IX, and XI procollagen mRNA in cartilage. Ann. NY Acad. Sci. 580: 512-513.
224. Van der Rest, M. and Garrone, R. (1991) Collagen family of proteins. FASEB J. 5: 2814-2823.
225. Van Lent, P. L. E. M., Vanden Berg, W. M., Schalkwijk, J., Van de Pulfe, L. B. A. and Van den Bersselaar, L. (1987) The impact of protein size and charge on its retention in articular cartilage. J. Rheumatol. 14: 798-805.
226. Van Wart, H. E. and Birkedal-Hansen, H. (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87: 5578-5582.
227. Varghese, S., Rydziel, S., Jeffrey, J. J. and Canalis, E. (1994) Regulation of interstitial collagenase expression and collagen degradation by retinoic acid in bone cells. Endocrinology 134: 2438-2444.
228. Vincenti, M. P., Clark, I. M. and Brinckherhoff, C. E. (1994) Using inhibitors of metalloproteinases to treat arthritis: easier said than done. Arthritis Rheum. 37: 1115-1126.
229. Walakovits, L. A., Moore, V. L., Bhardwaj, N., Gallick, G. S. and Lrk, M. W. (1992) Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum. 35: 35-42.
230. Watson, S. A., Morris, T. M., Robinson, G., Crimmin, M. J., Brown, P. D. and Hardcastle, J. D. (1995) Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res. 55: 3629-3633.
231. Welgus, H. G., Fliszar, C. J., Seltzer, J. L., Schmid, T. M. and Jeffrey, J. J. (1990) Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa type IV collagenase. J. Biol. Chem. 265: 13521-13527.
232. Wentworth, J. S., Paterson, C. A. and Gray, R. D. (1992) Effect of a metalloproteinase inhibitor on established corneal ulcers after an alkali burn. Invest. Ophthalmol. Vis. Sci. 33: 2174-2179.
233. Wilhelm, S. M., Shao, Z-H., Housley, T. J., Seperack, P. K., Baumann, A. P., Gunja-Smith, Z. and Woessner, J. F., Jr. (1993) Matrix metalloproteinase-3 (stromelysin-1). Identification as the cartilage acid metalloprotease and effect of pH on catalytic properties and calcium affinity. J. Biol. Chem. 268: 21906-21913.
234. Will, H. and Huymann, B. (1995) cDNA sequence and mRNA tissue distribution of a novel human MMP with a transmembrane segment. Eur. J. Biochem. 231: 602-608.
235. Willenbrock, F. and Murphy, G. (1994) Structure-function relationships in the tissue inhibitors of metalloproteinases. Am. J. Respir. Crit. Care Med. 150 (Suppl.): S165-S170.
236. Williamson, R. A., Marston, F. A., Angal, S., Koklitis, P., Panico, M., Morris, H. R., Carne, A. F., Smith, B. J., Harris, T. J. R. and Freedman, R. B. (1990) Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem. J. 268: 267-274.
237. Williamson, R. A., Martorell, G., Carr, M. D., Murphy, G., Docherty, A. J. P., Freedman, R. B. and Feeney, J. (1994) Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry 33: 11745-11759.
238. Windsor, L. J., Birkedal-Hansen, H., Birkedal-Hansen, B. and Engler, J. A. (1991) An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenase. Biochemistry 30: 641-647.
239. Windsor, L. J., Bodden, M. K., Birkedal-Hansen, B., Engler, J. A. and Birkedal-Hansen, H. (1994) Mutational analysis of residues in and around the active site of human fibroblast-type collagenase. J. Biol. Chem. 269: 26201-26207.
240. Woessner, J. (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154.
241. Wolf, C., Rouyer, N., Lutz, Y., Adida, C., Loriot, M., Bellocq, J., Chambon, P. and Basset, P. (1993) Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumour progression. Proc. Natl. Acad. Sci. USA 90: 1843-1847.
242. Wright, J. K., Cawston, T. E. and Hazleman, B. L. (1991a) Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts. Biochim. Biophys. Acta 1094: 207-210.
243. Wright, J. K., Clark, I. M., Cawston, T. E. and Hazleman B. L. (1991b) The secretion of the tissue inhibitor of metalloproteinases (TIMP) by human synovial fibroblasts is modulated by all-trans-retinoic acid. Biochim. Biophysi. Acta 1133: 25-30.
244. Yang, T. and Hawkes, S. P. (1992) Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chick embryo fibroblasts. Proc. Natl. Acad. Sci. USA 89: 10676-10680.
245. Yu, M., Sato, H., Seiki, M. and Thompson, E. W. (1995) Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MD-231 human breast cancer cells. Cancer Res. 55: 3272-3277.